The mixture based on 2,3-dichloro-1,4-naphthoquinone (dichlone) and silver nanoparticles exhibits strong antibacterial activity against resistant Pseudomonas aeruginosa.
The use of nanosilver activates and enhances the bactericidal properties of dichlone, creating a synergistic effect and significantly reducing the minimal effective doses required for bacterial elimination.
The developed solution combines high efficacy with low toxicity and can be used in topical formulations for treating wounds, burns, or skin infections.
This technology offers a promising alternative to conventional antibiotics in the face of growing antimicrobial resistance.
- Antibacterial preparations for treating wounds infected with P. aeruginosa
- Component of antiseptic creams, ointments, and wound dressings,
- Adjunct therapy for skin infections caused by resistant bacteria.
